No abstract available
MeSH terms
-
Administration, Oral
-
Anticoagulants / administration & dosage
-
Fibrin Fibrinogen Degradation Products / metabolism*
-
Humans
-
ROC Curve
-
Recurrence
-
Risk Factors
-
Thromboembolism / blood*
-
Thromboembolism / drug therapy
-
Thromboembolism / etiology*
-
Time Factors
-
Venous Thrombosis / blood*
-
Venous Thrombosis / drug therapy
-
Venous Thrombosis / etiology*
Substances
-
Anticoagulants
-
Fibrin Fibrinogen Degradation Products
-
fibrin fragment D